Clinical trials: Inflammatory Markers Changes in Response to Extra-corporeal Membrane Oxygenator Decannulation
Inflammatory Markers Changes in Response to Extra-corporeal Membrane Oxygenator Decannulation
Inflammatory Markers Dynamics in Response to Extra-corporeal Membrane Oxygenator Decannulation
Extracorporeal membrane oxygenation (ECMO) aim at providing cardiac, respiratory support, or both. The use of ECMO could be associated with systemic inflammatory response syndrome (SIRS) at the time of initiation or the time of…
- Trial name
- ECMO (NCT04678518)
- Testing
- Inflammatory makers that will include Interleukins (IL); IL1, IL2, IL6 and TNF
- Where
- 2 sites in Qatar
- Volunteers
- 30 people
- Sponsor
- Hamad Medical Corporation